Sab Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.17

+0.19 (+4.77%)

As of Feb 8, 2:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +653.2% upside

Low Target $26.29

Average Target $31.41

High Target $48.84

Current Price $4.17

Current
$4.17

Target
$31.41

$26.29 $31.41 avg $48.84

Scenario Analysis

Bear Case

$26.29

530.5%

Low target

Base Case

$31.41

+653.2%

Avg target

Bull Case

$48.84

+1,071.2%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$37.58

-88.9% from high

52-Week Low

$17.20

+-75.8% from low

Target vs 52W High

$31.41

-16.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%